Venturelab
close

TOP 100 Pitch Event With Credit Suisse Private Investors Club in Geneva

08.10.2019 16:50, Stefan Steiner

Together with our TOP 100 Presenting Partner Credit Suisse we are hosting exceptional startup pitch events to matchmake TOP 100 startups with investors.

At the Credit Suisse Private Investors Club evening in Geneva on 25 September 2019, handpicked investors and entrepreneurs listened to pitches from selected startups which were ranked in the previous TOP 100 Swiss Startup Awards and are now looking for financing.

After the welcome words by Pascal Besnard, Head of Credit Suisse Genève, Madiha Derouazi, CEO of Amal Therapeutics, shared her lessions learnt as entrepreneur. Amal Therapeutics was acquired this summer by Boehringer Ingelheim for up to €425 million. Jordi Montserrat, Managing Partner at Venturelab moderated the pitch session of the 5 handpicked startups from the Geneva region. The pitching startups benefited from the direct feedback and were able to create new fundraising and business opportunities thanks to the high-level networking. 

In the past, successful TOP 100 Pitch Events have already been held in Lausanne, Zurich and St. Gallen in collaboration with Credit Suisse. These events are invitation only. If you are not already on our list and would like to receive an invitation as an investor, please apply online

Amal Therapeutics SA : Cancer vaccines

Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors. Read more

Categories

Credit Suisse TOP 100